EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Iminosugar‐Dihydroazulenes as Mutant L444P Glucocerebrosidase Enhancers

Maria Giulia Davighi iD, Francesca Clemente iD, Emilie Sperling Andreasen iD, Mogens Brøndsted Nielsen iD, Camilla Matassini iD, Andrea Goti iD, Amelia Morrone iD, Paolo Paoli iD, Francesca Cardona iD, Martina Cacciarini iD

Chemistry & Biodiversity · 2024

DOI: 10.1002/cbdv.202401104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Maria Giulia Davighi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry "U. Schiff", University of Florence, via della Lastruccia 3-13, 50019, Sesto F.no (FI), Italy. Hauptthemen laut MEDLINE: Glucosylceramidase, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MUR, #NEXTGENERATIONEU (NGEU), Ministry of University and Research (MUR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A remarkable enhancer of human glucocerebrosidase enzyme (GCase) was identified among a set of dihydroazulene‐tagged iminosugars. An unprecedented 3.9‐fold increase in GCase activity was detected on fibroblasts bearing the homozygous L444P mutation, which is frequently associated with neuronopathic Gaucher forms, and which commonly results refractory to chaperone‐induced refolding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucosylceramidaseMutationHumansImino SugarsFibroblastsGaucher DiseaseMolecular Structure

Stichwörter der Autor:innen

Click chemistryEnzyme modulatorsGaucher diseaseNeuronopathic disorderPhotochromism

Substanzen

GlucosylceramidaseImino Sugars

Autor:innen und Institutionen

  • Department of Chemistry "U. Schiff", University of Florence, via della Lastruccia 3-13, 50019, Sesto F.no (FI), Italy.
  • Department of Chemistry, University of Copenhagen, Universitetsparken 5, DK-2100, Copenhagen Ø, Denmark.
  • Laboratory of Molecular Genetics of Neurometabolic Diseases, Department of Neuroscience and Medical Genetics, Meyer Children's Hospital IRCCS, Viale Pieraccini 24, 50139, Firenze, Italy.
  • Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, Viale Pieraccini 24, 50139, Firenze, Italy.
  • Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134, Firenze, Italy.

ORCID-Profile: Maria Giulia Davighi, Francesca Clemente, Emilie Sperling Andreasen, Mogens Brøndsted Nielsen, Camilla Matassini, Andrea Goti, Amelia Morrone, Paolo Paoli, Francesca Cardona, Martina Cacciarini

Förderung

  • MUR
  • #NEXTGENERATIONEU (NGEU)
  • Ministry of University and Research (MUR)
  • National Recovery and Resilience Plan (NRRP)
  • FONDAZIONE CARIPT
  • iDANEUROPARK
  • Regione Toscana
  • European Union - NextGenerationEUAward

Zitieren

APA

Davighi, M. G., Clemente, F., Andreasen, E. S., Nielsen, M. B., Matassini, C., Goti, A., Morrone, A., Paoli, P., Cardona, F., & Cacciarini, M. (2024). Iminosugar‐Dihydroazulenes as Mutant L444P Glucocerebrosidase Enhancers. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401104

Vancouver

Davighi MG, Clemente F, Andreasen ES, Nielsen MB, Matassini C, Goti A, et al. Iminosugar‐Dihydroazulenes as Mutant L444P Glucocerebrosidase Enhancers. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202401104

BibTeX
@article{Davighi2024,
  author = {Davighi, Maria Giulia and Clemente, Francesca and Andreasen, Emilie Sperling and Nielsen, Mogens Brøndsted and Matassini, Camilla and Goti, Andrea and Morrone, Amelia and Paoli, Paolo and Cardona, Francesca and Cacciarini, Martina},
  title = {Iminosugar‐Dihydroazulenes as Mutant L444P Glucocerebrosidase Enhancers},
  journal = {Chemistry & Biodiversity},
  year = {2024},
  doi = {10.1002/cbdv.202401104}
}
Kostenlos starten →